These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. COVID-19 Australia: Epidemiology Report 27: Fortnightly reporting period ending 11 October 2020. COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33087023 [TBL] [Abstract][Full Text] [Related]
31. COVID-19, Australia: Epidemiology Report 8 (Reporting period from 19:00 AEDT 14 March to 23:59 AEDT 22 March 2020). COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32223725 [TBL] [Abstract][Full Text] [Related]
32. COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020). COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32600222 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 Australia: Epidemiology Report 29: Fortnightly reporting period ending 8 November 2020. COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33238106 [No Abstract] [Full Text] [Related]
34. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses. Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236 [TBL] [Abstract][Full Text] [Related]
36. COVID-19 Australia: Epidemiology Report 50: Reporting period ending 12 September 2021. COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2021 Sep; 45():. PubMed ID: 34556015 [No Abstract] [Full Text] [Related]
37. How COVID vaccines shaped 2021 in eight powerful charts. Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666 [No Abstract] [Full Text] [Related]
38. Sex-based differences in severity and mortality in COVID-19. Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622 [TBL] [Abstract][Full Text] [Related]
39. Modelling the Transmission Dynamics of COVID-19 in Six High-Burden Countries. Rahman A; Kuddus MA Biomed Res Int; 2021; 2021():5089184. PubMed ID: 34124240 [TBL] [Abstract][Full Text] [Related]
40. Overview of the COVID-19 Pandemic in Japan: Public Health Perspectives in the first half of 2020. Suzuki Y Keio J Med; 2021 Dec; 70(4):73-81. PubMed ID: 34602536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]